Related Experiment Video
Updated: Dec 19, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Clinical interventions for severe and critical COVID-19: what are the options
1Department of Orthopedics, First Hospital of China Medical University Shenyang, China.
Insights
This review summarizes clinical interventions for severe COVID-19. It aims to guide healthcare providers in treating critical coronavirus disease 2019 patients.
Area of Science:
- Medical Research
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic poses a significant global health threat.
- Severe and critical cases of COVID-19 exhibit high mortality rates due to complications such as acute respiratory distress syndrome, acute respiratory failure, and multiple organ failure.
- Existing research on COVID-19 characteristics is extensive, but treatment strategies for severe and critical cases remain limited.
Purpose of the Study:
- To review and synthesize published evidence on clinical interventions for severe and critical COVID-19.
- To provide an updated reference for clinicians managing severe and critical COVID-19 cases.
Main Methods:
- A comprehensive literature review of published studies on clinical interventions for severe and critical COVID-19.
- Systematic evaluation of evidence regarding treatment efficacy and safety.
Main Results:
- The review identifies and analyzes various therapeutic approaches investigated for severe and critical COVID-19.
- Key findings on the effectiveness and limitations of different interventions are presented.
Conclusions:
- This review offers a consolidated overview of current treatment options for severe and critical COVID-19.
- The findings aim to inform clinical decision-making and guide future research in managing severe coronavirus disease 2019.
Abstract:
The coronavirus disease 2019 (COVID-19) has been ongoing outbreak and declared as a global public health emergency by the World Health Organization. Severe and critical COVID-19 has high fatality rate due to complications like acute respiratory distress syndrome, acute respiratory failure or multiple organ failure. So far, there have been mounting research on the epidemiological and clinical characteristics of COVID-19. However, the information regarding treatment of severe and critical COVID-19 is limited. The current study reviewed published evidence of clinical interventions of severe and critical COVID-19, aiming to provide an up-to-date reference for further clinical treatment.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

